Cargando…

Micro‐Engineered Organoid‐on‐a‐Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients

Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide. Patient‐derived organoid (PDO) has great potential in precision oncology, but low success rate, time‐consuming culture, and lack of tumor microenvironment (TME) limit its application. Mesenchymal stromal cells (MSC) accumula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Zhengyu, Lin, Zhun, Wu, Chenglin, Tan, Jizhou, Zhang, Jie, Peng, Yanwen, Zhang, Kunsong, Li, Jiaping, Wu, Minhao, Zhang, Yuanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520686/ https://www.ncbi.nlm.nih.gov/pubmed/37485650 http://dx.doi.org/10.1002/advs.202302640

Ejemplares similares

Application of microfluidic technologies on COVID-19 diagnosis and drug discovery
por: Lin, Zhun, et al.
Publicado: (2023)

Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy
por: Zhuang, Jialang, et al.
Publicado: (2020)

Nanomaterial-based Microfluidic Chips for the Capture and Detection of Circulating Tumor Cells
por: Sun, Duanping, et al.
Publicado: (2017)

High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39(+)CD8(+) T cells
por: Liu, Ting, et al.
Publicado: (2021)

A Dynamic 3D Tumor Spheroid Chip Enables More Accurate Nanomedicine Uptake Evaluation
por: Zhuang, Jialang, et al.
Publicado: (2019)

The CD39(+) HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8(+) T cells exhibit potent anti-HCC activity
por: Zou, Fan, et al.
Publicado: (2021)

Tetrahedral DNA nanostructures synergize with MnO(2) to enhance antitumor immunity via promoting STING activation and M1 polarization
por: Liang, Siping, et al.
Publicado: (2022)

Engineering Microfluidic Organoid-on-a-Chip Platforms
por: Yu, Fang, et al.
Publicado: (2019)

Review on the Vascularization of Organoids and Organoids-on-a-Chip
por: Zhao, Xingli, et al.
Publicado: (2021)

Tissue engineering of the retina: from organoids to microfluidic chips
por: Marcos, Luis F, et al.
Publicado: (2021)

The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

Coating with flexible DNA network enhanced T-cell activation and tumor killing for adoptive cell therapy
por: Zhang, Ziyan, et al.
Publicado: (2021)

New techniques: a roadmap for the development of HCC immunotherapy
por: Jiang, Dizhi, et al.
Publicado: (2023)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
por: Bicer, Fuat, et al.
Publicado: (2023)

Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)

A human kidney and liver organoid‐based multi‐organ‐on‐a‐chip model to study the therapeutic effects and biodistribution of mesenchymal stromal cell‐derived extracellular vesicles
por: Nguyen, Vivian V. T., et al.
Publicado: (2022)

Organoids, organs-on-chips and other systems, and microbiota
por: May, Stephanie, et al.
Publicado: (2017)

Organ chips, organoids and the animal testing conundrum
por: Horejs, Christine
Publicado: (2021)

HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway
por: Chen, Lu, et al.
Publicado: (2018)

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
por: Wang, Xiang-Xu, et al.
Publicado: (2022)

Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review
por: Zhu, Leqing, et al.
Publicado: (2023)

OrganoidChip facilitates hydrogel-free immobilization for fast and blur-free imaging of organoids
por: Moshksayan, Khashayar, et al.
Publicado: (2023)

A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy
por: Zhang, Bingchen, et al.
Publicado: (2021)

Commentary: Human brain organoid-on-a-chip to model prenatal nicotine exposure
por: Qiao, Haowen, et al.
Publicado: (2018)

Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery
por: Almeida-Porada, Graça, et al.
Publicado: (2020)

CXCR2 inhibition enables NASH-HCC immunotherapy
por: Leslie, Jack, et al.
Publicado: (2022)

Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities
por: Kwee, Sandi, et al.
Publicado: (2022)

Organoid Models for Precision Cancer Immunotherapy
por: Sun, Cai-Ping, et al.
Publicado: (2022)

Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications
por: Zeng, Xiao, et al.
Publicado: (2023)

Immunotherapy and Transarterial therapy of HCC: What the interventional radiologist needs to know about the changing landscape of HCC treatment?
por: Tibballs, Jonathan, et al.
Publicado: (2022)

Human Brain Organoids on a Chip Reveal the Physics of Folding
por: Karzbrun, Eyal, et al.
Publicado: (2018)

Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research
por: Duzagac, Fahriye, et al.
Publicado: (2021)

Human Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges
por: Wang, Yaqing, et al.
Publicado: (2022)

mRNA-engineered mesenchymal stromal cells expressing CXCR2 enhances cell migration and improves recovery in IBD
por: Li, Qiaojia, et al.
Publicado: (2021)

NASH limits anti-tumour surveillance in immunotherapy-treated HCC
por: Pfister, Dominik, et al.
Publicado: (2021)

Characterization of Hepatocellular Carcinoma Cell Lines Using a Fractionation-Then-Sequencing Approach Reveals Nuclear-Enriched HCC-Associated lncRNAs
por: Chow, Eugene Yui-Ching, et al.
Publicado: (2019)

Validation of a Lab-on-Chip Assay for Measuring Sorafenib Effectiveness on HCC Cell Proliferation
por: Piccinno, Emanuele, et al.
Publicado: (2021)

Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors
por: Yoon, A-Rum, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5vv9mdoe9cp619ls4tj4ool4l4